Cathy Tie is the founder and CEO of Locke Bio, a digital health platform company that streamlines the launch of fully integrated, branded telehealth services. Cathy is recognized in Silicon Valley as the youngest founder to raise venture capital in biotech, is a Thiel Fellow, and has been recognized by Forbes in their annual 30 under 30 listing. Cathy first became interested in biology at the age of 16, when she published her first research paper in a peer-reviewed journal. At 18, she left college to start her first company, Ranomics, a genomics screening service. She also has experience in venture capital, becoming the youngest partner to join Silicon Valley venture capital firm, Cervin Ventures, at the age of 22.
FORBES: Founded in 2019 by then 23-year-old entrepreneur, Thiel Fellow and Forbes 30 under 30 member Kathy Tie, B2B technology company Locke Bio is building the "Shopify" for the health industry. Its technology helps organizations launch a fully integrated, branded DTC pharmacy or telehealth service.
CNBC: Cathy Tie co-founded her first company at 18. At 26, she's now working on her second. She says thinking like an artist has helped build her success.
Industry Today: Using the power of e-commerce to sell directly to consumers can help manufacturers increase margins and offset inflationary pressures.